-
Signature
-
/s/ Louis J. Thorson, Attorney-in-Fact for Ban Seng Teh
-
Issuer symbol
-
STX
-
Transactions as of
-
12 Jan 2026
-
Net transactions value
-
-$329,411
-
Form type
-
4
-
Filing time
-
14 Jan 2026, 17:04:58 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Teh Ban Seng |
EVP & Chief Commercial Officer |
SEAGATE TECHNOLOGY HOLDINGS PLC, 47488 KATO ROAD, FREMONT |
/s/ Louis J. Thorson, Attorney-in-Fact for Ban Seng Teh |
14 Jan 2026 |
0001801425 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
STX |
Ordinary Shares |
Options Exercise |
$36,686 |
+533 |
+3.9% |
$68.83 |
14,226 |
12 Jan 2026 |
Direct |
F1 |
| transaction |
STX |
Ordinary Shares |
Options Exercise |
$56,528 |
+879 |
+6.2% |
$64.31 |
15,105 |
12 Jan 2026 |
Direct |
|
| transaction |
STX |
Ordinary Shares |
Sale |
$422,626 |
-1,412 |
-9.3% |
$299.31 |
13,693 |
12 Jan 2026 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
STX |
NQ Options |
Options Exercise |
$0 |
-533 |
-11% |
$0.000000 |
4,260 |
12 Jan 2026 |
Ordinary Shares |
533 |
$68.83 |
Direct |
F2 |
| transaction |
STX |
NQ Options |
Options Exercise |
$0 |
-879 |
-4.8% |
$0.000000 |
17,575 |
12 Jan 2026 |
Ordinary Shares |
879 |
$64.31 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: